<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="967d978d-d771-48c0-8caa-14c67e82ecd3"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Care-plan review) — Ann Richards — True-date frame: synthetic events are moved into the patient&apos;s historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.</title>
  <effectiveTime value="19970811120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="ac63085e-b6c1-4c47-a416-95d564bd8908"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="cf36cabd-8e85-432f-9f6a-bbcc9f68b7f1" extension="HR-ML019-SYN-TD"/>
      <id root="2.16.840.1.113883.4.1" extension="000-19-3381"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Ann</given><family>Richards</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19330901"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="19970811120000-0500"/>
    <assignedAuthor><id root="2ab7334a-f5df-43c8-805f-553339bfb144"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Teague</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="19970811120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="2ab7334a-f5df-43c8-805f-553339bfb144"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Teague</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="19970811"/><high value="19970811"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="2ab7334a-f5df-43c8-805f-553339bfb144"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Teague</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="f01dbdc7-6adf-4168-bca2-76a951ed3d6b"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Six-month bone health review, three months after the first infusion</originalText></code>
      <effectiveTime><low value="19970811"/><high value="19970811"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="2ab7334a-f5df-43c8-805f-553339bfb144"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Rosalind</given><family>Teague</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Six-month bone health review, three months after the first zoledronic acid infusion. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Richards returns three months after her first zoledronic acid infusion. The evening after the infusion she had aching muscles and a temperature of 37.9 °C, which settled with acetaminophen and were gone on the third day; she has had no symptoms since. She has had no muscle cramps, tingling, jaw pain, or thigh or groin pain. She takes vitamin D3 1971 units a day and keeps her calcium at about 1200 mg a day from food. She does the home balance program three times a week, walks most days, and has had no falls. She came fasting this morning for her blood tests. She has had no alcohol. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Infusion reaction</td><td>Aches and 37.9 °C for two days after the dose, settled with acetaminophen</td></tr><tr><td>Drug safety</td><td>No cramps, tingling, jaw pain, or thigh or groin pain</td></tr><tr><td>Supplements and diet</td><td>D3 1971 units daily; calcium about 1200 mg a day from food</td></tr><tr><td>Falls</td><td>None; home balance program three times a week</td></tr><tr><td>Recovery</td><td>No alcohol; no cravings</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Negative</td><td>No fever or fatigue since the third day after the infusion</td></tr><tr><td>Musculoskeletal</td><td>Negative</td><td>No bone, thigh, or groin pain; no muscle cramps</td></tr><tr><td>Ears, nose, mouth, and throat</td><td>Negative</td><td>No jaw pain, loose teeth, or mouth sores</td></tr><tr><td>Eyes</td><td>Negative</td><td>No eye pain or redness</td></tr><tr><td>Psychiatric</td><td>Negative</td><td>Mood good; no cravings; no thoughts of self-harm</td></tr></tbody></table><paragraph>5 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Cholecalciferol (vitamin D3) 50 mcg (1971 units) oral tablet, one tablet daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>1997-02-10</td><td>active</td><td>S</td></tr><tr ID="medication-2"><td>Zoledronic acid 5 mg in 100 mL intravenous infusion over 30 minutes, once every 12 months</td><td>Once every 12 months, given in the clinic infusion room after a calcium and creatinine check</td><td>Intravenous route</td><td>1997-05-12</td><td>active</td><td>S</td></tr><tr ID="medication-3"><td>Acetaminophen 500 mg oral tablet, two tablets every 6 hours as needed for aches or fever for up to three days after the infusion (no more than 3 g a day)</td><td>Two tablets every 6 hours as needed for up to three days after the infusion</td><td>Oral route</td><td>1997-05-12 to 1997-05-15</td><td>completed</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="6e7623c2-aed5-402b-84f2-72cdded6a00e"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19970210"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="50" unit="ug"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="801663" codeSystem="2.16.840.1.113883.6.88" displayName="cholecalciferol 0.05 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5ead2744-ebcb-4d0d-8d5a-ffd5343f27a0"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="e0741e50-a0d7-447e-8fb4-ec4472102b03"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19970512"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="52" unit="wk"/></effectiveTime>
      <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Intravenous route"/>
      <doseQuantity value="5" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="705824" codeSystem="2.16.840.1.113883.6.88" displayName="100 ML zoledronic acid 0.05 MG/ML Injection"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="39cbfb05-3e5b-459b-95f9-7c17bd6cd330"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="13edc089-736a-4437-9f38-d1e0dc0fa9c0"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="19970512"/><high value="19970515"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="6" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1000" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198440" codeSystem="2.16.840.1.113883.6.88" displayName="acetaminophen 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="fd808f83-ba90-443a-9b98-f5630b6dfdae"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="30d96852-3736-416b-9c18-946f4e7f019e"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19970210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="e0ddf632-5af7-43e9-b73a-f0c03dde3b6e"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-4-1"><td>1997-08-11</td><td>Body height</td><td>164</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-4-2"><td>1997-08-11</td><td>Body weight</td><td>66</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-4-3"><td>1997-08-11</td><td>Body mass index (BMI) [Ratio]</td><td>24.5</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-4-4"><td>1997-08-11</td><td>Systolic blood pressure</td><td>122</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-4-5"><td>1997-08-11</td><td>Diastolic blood pressure</td><td>76</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-4-6"><td>1997-08-11</td><td>Heart rate</td><td>68</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-4-7"><td>1997-08-11</td><td>Respiratory rate</td><td>14</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-4-8"><td>1997-08-11</td><td>Body temperature</td><td>36.7</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-4-9"><td>1997-08-11</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>98</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="98432029-dbd1-40eb-b8ae-32d066bcf1e2"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="19970811"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="3218913b-af05-4fe0-9c4f-bc1672d6445f"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-4-1"/></text><statusCode code="completed"/><effectiveTime value="19970811"/><value xsi:type="PQ" value="164" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="57215a03-1a05-4504-8a42-3fb4a01ff742"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-4-2"/></text><statusCode code="completed"/><effectiveTime value="19970811"/><value xsi:type="PQ" value="66" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="493da324-fb7c-4e79-bbf7-df18b0e25f6a"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-4-3"/></text><statusCode code="completed"/><effectiveTime value="19970811"/><value xsi:type="PQ" value="24.5" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="958e583f-f096-4a56-972d-fdd89201e15d"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-4-4"/></text><statusCode code="completed"/><effectiveTime value="19970811"/><value xsi:type="PQ" value="122" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="e369cbb9-37cd-48a0-8592-4ccfc2ac5ddb"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-4-5"/></text><statusCode code="completed"/><effectiveTime value="19970811"/><value xsi:type="PQ" value="76" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5e9b6678-c6ef-4d94-bb60-f2ddd0933ad0"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-4-6"/></text><statusCode code="completed"/><effectiveTime value="19970811"/><value xsi:type="PQ" value="68" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="1ddcde81-be35-462e-8f9e-6434bfc0f06e"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-4-7"/></text><statusCode code="completed"/><effectiveTime value="19970811"/><value xsi:type="PQ" value="14" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="8da362fa-85c9-4395-9d84-22d8e396a766"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-4-8"/></text><statusCode code="completed"/><effectiveTime value="19970811"/><value xsi:type="PQ" value="36.7" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="e4fcd63c-f822-46d7-b4c4-b5e6eb5d86c7"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-4-9"/></text><statusCode code="completed"/><effectiveTime value="19970811"/><value xsi:type="PQ" value="98" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-26"><td>1997-08-11</td><td>Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma</td><td>190</td><td>pg/mL</td><td>Postmenopausal reference interval 104 to 1008 pg/mL; a fall of more than about 30 percent on antiresorptive therapy indicates response</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-27"><td>1997-08-11</td><td>Calcium [Mass/volume] in Serum or Plasma</td><td>9.3</td><td>mg/dL</td><td>8.6-10.3 mg/dL</td><td>Normal</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="d1b5d5bd-8d6c-466d-bb5d-8b11d11a29fa"/>
      <code code="41171-0" codeSystem="2.16.840.1.113883.6.1" displayName="Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19970811"/><high value="19970811"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="7ce3e3f1-1e16-4749-84aa-0f4e7e61321a"/>
          <code code="41171-0" codeSystem="2.16.840.1.113883.6.1" displayName="Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-26"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19970811"/>
          <value xsi:type="PQ" value="190" unit="pg/mL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>Postmenopausal reference interval 104 to 1008 pg/mL; a fall of more than about 30 percent on antiresorptive therapy indicates response</text>
              <value xsi:type="IVL_PQ"><low value="104" unit="pg/mL"/><high value="1008" unit="pg/mL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="7786af9b-1fa7-4321-a6bc-57cb79b63aa0"/>
      <code code="17861-6" codeSystem="2.16.840.1.113883.6.1" displayName="Calcium [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="19970811"/><high value="19970811"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="57fa4669-8ec1-4738-aeee-fddffee48bcf"/>
          <code code="17861-6" codeSystem="2.16.840.1.113883.6.1" displayName="Calcium [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-27"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="19970811"/>
          <value xsi:type="PQ" value="9.3" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>8.6-10.3 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="8.6" unit="mg/dL"/><high value="10.3" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 1997-08-11; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; weight 66.0 kg</td></tr><tr><td>Mouth</td><td>No exposed bone or gum swelling</td></tr><tr><td>Musculoskeletal</td><td>No thigh tenderness; full painless hip movement</td></tr><tr><td>Gait and balance</td><td>Timed Up and Go 9 seconds; tandem stance 20 seconds</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Low bone mass (osteopenia) of the lumbar spine and hip on DXA, lowest T-score -2.3 at the lumbar spine (femoral neck -2.0, total hip -1.7), with a 10-year FRAX risk above the treatment thresholds (major osteoporotic fracture 22 percent, hip 3.6 percent); not osteoporosis by T-score, but meets the AACE 1991 clinical criteria for osteoporosis (low bone mass with a FRAX risk above threshold)</td><td>active</td><td>confirmed</td>
    <td>M85.89</td><td>S — Synthetic modern DXA and FRAX classification linked to her publicly described osteopenia (early osteoporosis) after a fall with a hand fracture.</td>
  </tr>
  <tr ID="problem-2">
    <td>Alcohol use disorder in sustained remission for more than fifteen years, since treatment; no alcohol since</td><td>active</td><td>confirmed</td>
    <td>F10.21</td><td>S — Synthetic modern coding of her publicly described heavy drinking and long recovery; listed because remission protects bone and lowers fall risk, and it is reviewed at each visit.</td>
  </tr>
  <tr ID="problem-3">
    <td>History of falls: a fall from standing height with a hand fracture last year (and, in one account, a second fall with an ankle fracture); no falls since</td><td>active</td><td>confirmed</td>
    <td>Z91.81</td><td>S — Synthetic modern entry linked to her publicly described falls and fractures.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="a215081d-d4f9-4b13-b6e6-522a88451f99"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19970210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="b231c328-3d2b-4499-b055-8b7b04be5e6f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19970210"/></effectiveTime>
          <value xsi:type="CD" code="M85.89" codeSystem="2.16.840.1.113883.6.90" displayName="Other specified disorders of bone density and structure, multiple sites"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="05b02fab-b5b8-4598-9a6b-0f3c44a016c5"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19970210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="b0c8ef57-c926-4af7-9b32-f7811538fa55"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19970210"/></effectiveTime>
          <value xsi:type="CD" code="F10.21" codeSystem="2.16.840.1.113883.6.90" displayName="Alcohol dependence, in remission"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="54c41348-ca55-41c4-a28c-fbe9d8f72404"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="19970210"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="3a1a5396-39ef-417a-988d-ccacbd3ca550"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="19970210"/></effectiveTime>
          <value xsi:type="CD" code="Z91.81" codeSystem="2.16.840.1.113883.6.90" displayName="History of falling"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Low bone mass with high fracture risk, on zoledronic acid (M85.89)</content>. Fasting CTX 190 pg/mL, 66 percent lower than the baseline of 560, showing the expected response. Calcium 9.3 mg/dL. The acute-phase reaction after the first dose was mild and brief and usually does not recur with later doses. No signs of osteonecrosis of the jaw or atypical femoral fracture. [S]<list><item>Continue vitamin D3 1971 units daily and calcium from food.</item><item>Second yearly dose in May after calcium, creatinine, and 25-hydroxyvitamin D.</item><item>DXA two years after starting; reassess for a drug holiday after the third yearly dose.</item></list></item><item><content styleCode="Bold">History of falls (Z91.81)</content>. No falls in six months; balance gains kept up with the home program. [S]<list><item>Continue the home balance and strength program.</item></list></item><item><content styleCode="Bold">Alcohol use disorder in sustained remission (F10.21)</content>. No alcohol or cravings. Safety reviewed: no thoughts of suicide or self-harm; the 988 Suicide &amp; Crisis Lifeline is saved in her phone. [S]<list><item>Continue the recovery check at each visit.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>Bone-turnover marker (fasting serum CTX)</td><td>Baseline, then 3 to 6 months after starting or changing therapy</td><td>Completed today</td><td>190 pg/mL, 66 percent below the baseline of 560; response and adherence confirmed</td></tr><tr><td>Laboratory</td><td>Serum calcium</td><td>Before each zoledronic acid dose, and after the first dose if symptoms suggest hypocalcemia</td><td>Completed today</td><td>9.3 mg/dL, normal; checked with the CTX sample</td></tr><tr><td>Laboratory</td><td>25-hydroxyvitamin D</td><td>After repletion until 30 ng/mL or more; then yearly</td><td>Up to date</td><td>38 ng/mL in May; next with the pre-infusion tests in May</td></tr><tr><td>Medication safety</td><td>Acute-phase reaction after zoledronic acid</td><td>After the first dose</td><td>Completed today</td><td>Aches and 37.9 °C for two days, settled with acetaminophen; acetaminophen offered again for the next dose</td></tr><tr><td>Medication safety</td><td>Osteonecrosis of the jaw and atypical femoral fracture symptoms</td><td>At each visit on antiresorptive therapy</td><td>Completed today</td><td>No jaw pain or exposed bone; no thigh or groin pain; routine dental care twice a year</td></tr><tr><td>Imaging</td><td>Central DXA of the spine and hip</td><td>Every 1 to 2 years on therapy until stable, on the same scanner</td><td>Up to date</td><td>Due two years after starting therapy, on the same scanner</td></tr><tr><td>Examination</td><td>Standing height by stadiometer</td><td>Yearly; vertebral imaging again if height falls 2 cm or more</td><td>Up to date</td><td>164.0 cm, unchanged</td></tr><tr><td>Examination</td><td>Fall-risk screen</td><td>Yearly, and with any fall</td><td>Completed today</td><td>Timed Up and Go 9 seconds, tandem stance 20 seconds; no falls</td></tr><tr><td>Survey</td><td>FRAX 10-year fracture risk</td><td>At baseline, when risk factors change, and at the drug-holiday decision</td><td>Up to date</td><td>No change in risk factors; next at the drug-holiday decision</td></tr><tr><td>Survey</td><td>Calcium intake assessment</td><td>At baseline and yearly</td><td>Up to date</td><td>About 1200 mg a day from food</td></tr><tr><td>Medication safety</td><td>Drug-holiday eligibility</td><td>After 3 yearly zoledronic acid doses or 5 years of an oral bisphosphonate</td><td>Not indicated</td><td>One dose so far; reassess after the third yearly dose</td></tr><tr><td>Self-management</td><td>Balance and strength exercise program</td><td>With a history of falls or impaired balance</td><td>Up to date</td><td>Home program three times a week</td></tr><tr><td>Self-management</td><td>Recovery check (alcohol, cravings, stress)</td><td>Every visit</td><td>Completed today</td><td>No alcohol; no cravings</td></tr><tr><td>Survey</td><td>Suicide-risk review and safety plan, with the 988 Suicide &amp; Crisis Lifeline</td><td>Every visit</td><td>Completed today</td><td>No thoughts of suicide or self-harm; the 988 Suicide &amp; Crisis Lifeline is saved in her phone</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>Total calcium intake of about 1200 mg a day, mostly from food, by the four-week visit. Outcome by 1997-03-10: About 1200 mg a day from food by her own three-day food record [S]</item><item>25-hydroxyvitamin D of 30 ng/mL or more before the first infusion. Outcome by 1997-05-12: 24 ng/mL at intake and 38 ng/mL at three months [S]</item><item>First zoledronic acid dose by the three-month visit, with normal calcium and kidney function and a dental check done. Outcome by 1997-05-12: Given at three months after normal calcium (9.5 mg/dL) and eGFR (81) and a routine dental examination [S]</item><item>Complete the eight-week balance and strength program, with no falls through six months. Outcome by 1997-08-11: 16 of 16 sessions; Timed Up and Go 9 seconds and tandem stance 20 seconds at six months; no falls [S]</item><item>Serum CTX at least 30 percent lower three months after the first dose. Outcome by 1997-08-11: 560 pg/mL at baseline and 190 pg/mL at three months after the dose (66 percent lower) [S]</item><item>Sustained remission from alcohol use disorder throughout the episode. Outcome by 1997-08-11: No alcohol reported at any visit; AUDIT-C 0 at intake [S]</item></list><paragraph>Guideline basis: CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026); The clinician&apos;s guide to prevention and treatment of osteoporosis (2022); American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis, 2020 Update (2020); Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline (2019); STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)</paragraph><paragraph>Follow-up: Adult preventive visit in October. Second zoledronic acid dose in May with pre-infusion tests. Call for jaw pain, thigh or groin pain, or any fall. Next scheduled visit 1997-10-06: adult preventive visit. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
